---
figid: PMC7057654__12935_2020_1147_Fig2_HTML
figtitle: Vaccinations can inhibit the release of various pro-tumor cytokines
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Listeria monocytogenes
pmcid: PMC7057654
filename: 12935_2020_1147_Fig2_HTML.jpg
figlink: pmc/articles/PMC7057654/figure/Fig2/
number: F2
caption: Vaccinations can inhibit the release of various pro-tumor cytokines. Programmed
  death-1 ligand (PD-L1) inhibits the antitumor effects of Dendritic cell (DC) immunization
  and regulates regulatory T cells (Treg) which as a result upregulate IL-10 and IL-2
  as well as downregulate IFN-γ. 2) ARF6/AMAP1 signaling pathway is closely correlated
  with the intracellular recycling of PD-L1. Inhibition of ARF6/AMAP1 can reduce PD-L1
  cell surface expression. 3) Tumor antigens in PC such as telomerase, enolase, WT1,
  and mesothelin can stimulate cancer-specific T-cell responses. For example, CD4+
  and CD8+ T cells that specifically target mesothelin can be enhanced by vaccination.
  4) Vaccines such as live attenuated bacteria expressing mesothelin (CRS-207) and
  GM-CSF transduced allogeneic whole tumor cell vaccine (GVAX) can improve the immune
  system in PC by stimulating anti-tumor T cell infiltration. (+) Promote (−) Inhibit
papertitle: 'Novel therapeutic strategies and perspectives for metastatic pancreatic
  cancer: vaccine therapy is more than just a theory.'
reftext: Wenhao Luo, et al. Cancer Cell Int. 2020;20:66.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9755143
figid_alias: PMC7057654__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7057654__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7057654__12935_2020_1147_Fig2_HTML.html
  '@type': Dataset
  description: Vaccinations can inhibit the release of various pro-tumor cytokines.
    Programmed death-1 ligand (PD-L1) inhibits the antitumor effects of Dendritic
    cell (DC) immunization and regulates regulatory T cells (Treg) which as a result
    upregulate IL-10 and IL-2 as well as downregulate IFN-γ. 2) ARF6/AMAP1 signaling
    pathway is closely correlated with the intracellular recycling of PD-L1. Inhibition
    of ARF6/AMAP1 can reduce PD-L1 cell surface expression. 3) Tumor antigens in PC
    such as telomerase, enolase, WT1, and mesothelin can stimulate cancer-specific
    T-cell responses. For example, CD4+ and CD8+ T cells that specifically target
    mesothelin can be enhanced by vaccination. 4) Vaccines such as live attenuated
    bacteria expressing mesothelin (CRS-207) and GM-CSF transduced allogeneic whole
    tumor cell vaccine (GVAX) can improve the immune system in PC by stimulating anti-tumor
    T cell infiltration. (+) Promote (−) Inhibit
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il4
  - Il10
  - Hif1a
  - Tgfb1
  - Ltbp1
  - Il2
  - Pdcd1
  - Mycbpap
  - Prdx2
  - Cd274
  - Arf6
  - Kras
  - Wt1
  - IL4
  - IL10
  - HIF1A
  - TGFB1
  - TGFB2
  - TGFB3
  - IL2
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - TAM
  - STIM1
  - ASAP1
  - MYCBPAP
  - CD274
  - ARF6
  - KRAS
  - NRAS
  - WT1
  - TAM
  - Rapamycin
  - Silvestrol
  - cancer
---
